Seeking Alpha The study is comparing paclitaxel, M402, and gemcitabine to paclitaxel, placebo, and gemcitabine . The second part of the study won't begin until the middle of 2014 so this drug is a long way out from being on the market, but it is an interesting ... and more »
NASDAQ (CELG) said the U.S. Food and Drug Administration has assigned a priority review designation to its supplemental new drug application for Abraxane in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer. and more »
Wall Street Journal (CELG) said the U.S. Food and Drug Administration has assigned a priority review designation to its supplemental new drug application for Abraxane in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer. and more »
NutraIngredients-usa.com The use of IV-administered vitamin C in combination with cytotoxic chemotherapy is further encouraged by a recent report showing that vitamin C ...
NASDAQ ( CELG ) said the U.S. Food and Drug Administration has assigned a priority review designation to its supplemental new drug application for Abraxane in combinatio...
Canada NewsWire (press release) This trial will be the seventh randomized Phase 2 clinical trial evaluating OGX-427 in the treatment of advanced cancers and will investigate whether adding OGX-427 to gemcitabine and carboplatin therapy can extend progression-free survival (PFS) ... and more »
Healio Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control after first-line treatment with six cycles of the same combination, according to results of a phase 3 ...
